HCA Healthcare stock gains 1.83 percent on analyst support

HCA Healthcare stock (ISIN US40412C1018) was trading at USD 440.12 on the NYSE on October 7, 2026, up 1.83 percent at 11:03 a.m. ET. Cantor Fitzgerald reiterated its Overweight rating and USD 525.00 price target on October 6, 2026, giving the latest move a clear analyst backdrop.

Analyst target stays above the stock

According to Investing.com on October 6, 2026, Cantor Fitzgerald cited stable labor conditions and retained the USD 525.00 target. The target lies 19.3 percent above the USD 440.12 price, while the firm pointed to projected admissions growth of 1.9 percent in the second half of 2026.

The broader consensus is also constructive. MarketBeat lists a Moderate Buy rating from 24 analysts, an average target of USD 463.70, a high target of USD 579.00 and a low target of USD 380.00.

Q2 growth meets payer pressure

HCA Healthcare generated USD 20.23 billion in second-quarter 2026 revenue, up 8.7 percent from the year-ago period, while diluted EPS rose 11.6 percent to USD 7.62. The figures are reported in the Financial Report Insights analysis of the quarter.

Net income attributable to HCA increased 2.8 percent to USD 1.699 billion in Q2 2026, while the reported operating margin was 15.3 percent. Same-facility admissions increased 2.5 percent, but same-facility inpatient surgeries fell 2.3 percent and outpatient surgeries declined 3.4 percent.

Coverage mix remains the key risk

The quarter also showed why revenue growth does not translate directly into earnings visibility. Same-facility uninsured admissions rose 23.4 percent year over year, and the analysis said HCA faced an estimated USD 400 million pre-tax impact from patients losing exchange coverage.

HCA's 2026 adjusted diluted EPS guidance stands at USD 28.70-30.50, while adjusted EBITDA guidance is USD 15.40-16.10 billion. The combination of higher uninsured admissions and lower surgical volume leaves payer mix and service mix as the central operating variables for the next report.

October earnings date is set

HCA Healthcare has scheduled its third-quarter 2026 earnings call for October 27, 2026, at 10:00 a.m. ET, according to the company's Business Wire release dated September 30, 2026. That event will test whether admission growth can offset the pressure visible in the Q2 payer data.

HCA Healthcare stock trades above USD 440

HCA Healthcare stock was last at USD 440.12 on the NYSE on October 7, 2026 at 11:03 a.m. ET. The session range was USD 427.59 to USD 442.50, and the 52-week range was USD 353.99 to USD 556.52.

Upcoming dates for HCA Healthcare stock

• October 27, 2026: Third-quarter 2026 earnings call

More news and analyses on HCA Healthcare stock